California Public Employees Retirement System’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
Other funds holding RGLS
NMC
BI
SCM
CH
TRCT
California Public Employees Retirement System's RGLS Position: Q4 2020 in Review
California Public Employees Retirement System sold out of Regulus Therapeutics (RGLS) in Q4 2020, closing a stake of 1,480 shares — an estimated $8K sold.
California Public Employees Retirement System first reported a position in RGLS in Q2 2013 and held it in 29 quarters. The position peaked at $1.99M in Q4 2015. 31 funds tracked by Wall St. Rank hold RGLS as of Q4 2020.
- California Public Employees Retirement System reported no remaining Regulus Therapeutics position as of Q4 2020 after selling out during the quarter.
- California Public Employees Retirement System sold 1,480 Regulus Therapeutics shares in Q4 2020, an estimated $8K.
- California Public Employees Retirement System first reported a position in Regulus Therapeutics in Q2 2013 and held it in 29 quarters.
- California Public Employees Retirement System's Regulus Therapeutics position peaked at $1.99M in Q4 2015.
- 31 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q4 2020.
Based on California Public Employees Retirement System's 13F filing for Q4 2020, filed 2 Feb 2021.